Marr Technologies Clarifies Ownership Position in Calypte Biomedical Member of the Marr Group Acquired a Total of 5.4 Million Shares Through Open Market Purchase of Stock bringing total Calypte holdings to 38,915,151 LONDON, Nov. 3 /PRNewswire-FirstCall/ -- Marr Technologies Limited, a member of the Marr Group, clarified its ownership position in Calypte Biomedical (BULLETIN BOARD: CYPT) today. According to a recent filing, the investment group owns 38,915,151 shares of Calypte's common stock. It acquired 33,515,151 of these shares directly from the company through private placements comprising two subscriptions for 8,333,333 and 20,000,000 shares respectively and conversion of a debenture for 5,181,818 shares. In addition, the company has acquired 5.4 million shares via open market purchases. The purchase prices for the shares acquired in the open market ranged from $0.1225 to $1.31. "We remain highly confident in Calypte's HIV screening technology," said Marat Safin, President of Marr Technologies Limited. "This is why we elected to increase our already sizable investment in the company though open market purchases. Unfortunately, there has been some misinformation and misinterpretation about the way these shares were acquired. The 5.2 million shares, which were referred to in a press release Calypte issued on October 2, 2003 were acquired through open market purchases, and not via private sales or convertible financing structures. We hope our coming forward will allow investors to focus on the potential for the company's technology." About Marr Technologies Limited Marr Technologies Limited is a member of the Marr Group of companies (the "Group"). The Group is a private group controlled by the Safin family and administered from London. Marat Safin, a London School of Economics graduate, is the President of the Group. The Group has a large and diverse number of investments and projects globally, principally in Europe, the Far East, the Middle East and the CIS, with substantial investments in telecoms and technology projects. CONTACT: Andy D Brown, Advisor to the Marr Group; 011-44-207627-9898 DATASOURCE: Marr Technologies Limited CONTACT: Andy D Brown, Advisor to the Marr Group, +011-44-207627-9898,

Copyright